Programmed cell death (apoptosis) in cord blood lymphocytes

Journal of Clinical Immunology

Volumn 17, Issue 1, 1997, Pages 63-73

  Aggarwal, Sudeepta ^a   Gupta, Abha ^b   Nagata, Shigekazu ^c   Gupta, Sudhir ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Western Medical Center   (United States)

^c OSAKA BIOSCIENCE INSTITUTE   (Japan)

Author keywords

apoptosis; bcl 2; cord blood; fas

Indexed keywords

CD3 ANTIGEN; DNA FRAGMENT; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA;

APOPTOSIS; ARTICLE; GENE EXPRESSION; HUMAN; HUMAN CELL; NEWBORN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD95; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; FAS LIGAND PROTEIN; FETAL BLOOD; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; T-LYMPHOCYTE SUBSETS;

EID: 0031045352     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027340529644     Document Type: Article

References (55)

1. Stutman O: Ontogeny of T cells. Clin Immunol Allergy 5:191-196, 1985
2. Takahashi N, Imanishi K, Nishidu H, Uchiyama T: Evidence for immunologic immaturity of cord blood T cells. Cord blood T cells are susceptible to tolerance induction to in vitro stimulation with a superantigen. J Immunol 155:5213-5219, 1995
3. Aggarwal S, Gupta A, Gupta S: Differential expression of P-glycoprolein in cord blood and peripheral blood lymphocyte subpopulations, Int J Oncol 8:1063-1068, 1996
4. McDougall RM, Suitters AJ, Smith H, Yacoh MH, Rose ML: Increased cyclosporin sensitivity of T cells from cord blood compared with those from the adult. Clin Exp Immunol 95:519-524, 1994
5. Kavelaars A, Zijlstra J, Bakkar JM, Van Rees EP, Visser GH, Zegers BJ, Heijnen CJ: Increased dexamethasone sensitivity of neonatal leukocytes: Different mechanisms of glucocorticoid inhibition of T cell proliferation in adult and neonatal cells. Eur J Immunol 25:1346-1351, 1995
6. Cohen JJ, Duke RC, Fadok VA, Sellins KS: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267-293, 1992
7. Boise LH, Gottschalk AR, Quintans J, Thompson CB: Bcl-2 and Bcl-2 related proteins in apoptosis regulation. Curr Topics Microbiol Immunol 200:107-121, 1995
8. Korsmeyer SJ: Regulators of cell death. Trends Genet 11:101-105, 1995
9. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
10. Osborne BA: Induction of genes during apoptosis: Examples from immune system. Semin Cancer Biol 6:27-33, 1995
11. Reed JC: Bcl-2 family proteins: Regulators of chemoresistance in cancer. Toxicol Lett 82-83:155-158, 1995
12. Itoh N, Yonehara S, Ishil A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233-243, 1991
13. Reed JC: Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9:451-474, 1995
14. Hockenbery D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
15. I, can confer multidrug resistance phenotype. Blood 86:1903-1910, 1995
16. Krajewski S, Blomvqvist C, Franssila K, Krajewska M, Wasenius V-M, Niskanen E, Reed JC: Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 55:4471-4478, 1995
17. Alderson MR, Tough TW, Davis-Smith T, Braddy S, Falk B, Schooley KA, Goodwin RG, Smith CA, Ramsdell F, Lynch DH: Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 181:71-77, 1995
18. Yonehara S, Ishii A, Yonehara M: A cell killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169:1747-1756, 1989
19. Kobayashi N, Hamamoto Y, Yamamoto N, Ishii A, Yonehara M, Yonehara S: Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus infected cells without augmenting viral replication. Proc Natl Acad Sci USA 87:9620-9624, 1990
20. Nagafuji K, Shibuya T, Harada M, Mizuno S-I, Takenaka K, Miyamoto T, Okamura T, Gondo H, Niho Y: Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86:883-889, 1995
21. Kitada S, Miyashita T, Tanaka S, Reed JC: Investigations of antisense oligonucleotides targeted against bcl-2 RNAs. Antisense Res Dev 3:157-169, 1993
22. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597-608, 1993
23. Martinez-Valdez H, Guret C, de Bouteiller O, Fugier I, Banchereau J, Liu Y-J: Human germinal center B cells express the apoptosis-inducing genes fax, c-myc, p53, and bax but not the survival gene bcl-2. J Exp Med 183:971-977, 1995
24. Suda T, Takahashi T, Golstein P, Nagata S: Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178, 1993
25. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in homeostatic regulation of immune responses. Immunol Today 16:569-572, 1995
26. Vignaux F, Vivier E, Malissen B, Depraetere V, Nagata S, Goldstein P: TCR/CD3 coupling to Fas based cytotoxicity. J Exp Med 181:781-786, 1995
27. Liotta LA, Stetler-Stevenson WG: Metalloproteinases and cancer invasion. Semin Cancer Biol 1:99-106, 1990
28. Boone TC, Johnson MJ, De Clerck YA, Langley KE: cDNA cloning and expression of a metalloproteinase inhibitor related to tissue inhibitor of metalloproteinases. Proc Natl Acad Sci USA 87:2800-2804, 1990
29. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyashi K, Drummond AH, Nagata S: Fas ligand in human serum. Nature Med 2:317-322, 1996
30. Gavrieli Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119:493-501, 1992
31. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G: Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 10:41-42, 1994
32. Mochizuki H, Nakamura N, Nishi K, Mizuno Y: Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP) in ventral mesencephalic striatal co-culture in rat. Neurosci Lett 170:191-194, 1994
33. Portera-Cailliau C, Sung CH, Nathans J, Adler R: Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc Natl Acad Sci USA 91:974-978, 1994
34. Guilhot S, Miller T, Cornman G, Isom HC: Apoptosis induced by tumor necrosis factor-α in rat hepatocyte cell lines expressing hepatitis B virus. Am J Pathol 148:801-814, 1996
35. (low) T cells in newborn blood. Biol Neonate 69:128-132, 1996
36. Chleq-Deschamps CM, LeBrun DP, Huie P, Besnier DP, Warnke RA, Sibley RK, Cleary ML: Topographical dissociation of bcl-2 messenger RNA and protein expression in human lymphoid tissues. Blood 81:293-298, 1993
37. Nunez G, Merino R, Grillot D, Gonzalez-Garcia M: Bcl-2 and Bcl-x: Regulatory switches for lymphoid death and survival. Immunol Today 15:582-588, 1994
38. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 47:609-619, 1993
39. Yin XM, Oltvai ZN, Korsmeyer SJ: Heterodimerization with Bax is required for Bcl-2 to repress cell death. Curr Topics Microbiol Immunol 194:331-338, 1995
40. Owen-Schaub LB, Yonehara S, Crump WL III, Grimm E: DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 140:197-205, 1995
41. Golstein P, Ojcius DM, Young JD-E: Cell death mechanism and the immune system. Immunol Rev 121:129-165, 1991
42. Cohen JJ, Duke RC: Apoptosis and programmed cell death in immunity. Annu Rev Immunol 10:267-293, 1992
43. Smith SW, McLaughin KA, Osborne BA: Molecular events in thymocyte apoptosis. Curr Topics Microbiol Immunol 200:147-162, 1995
44. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Lin AY, Strober W, Lenardo MJ, Puck JM: Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935-946, 1995
45. Lynch DH, Ramsdell F, Alderson MR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16:569-574, 1995
46. Cohen PL, Eisenberg RA: Lpr and gld: Single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243-262, 1991
47. Russell JH: Activation-induced death of mature T cells in the regulation of immune responses. Curr Opin Immunol 7:382-388, 1995
48. Wanatabe-Fukunaga R, Brannan CL, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992
49. Takashi R, Tanaka M, Brannan CL, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76:969-976, 1994
50. + T cells and monocytes. Cell Immunol 163:303-308, 1995
51. Ozaizu N, Pahwa S: Role of apoptosis in HIV disease pathogenesis. J Clin Immunol 15:217-231, 1995
52. Kotani T, Aratake Y, Kondo S, Tamura K, Ohtaki S: Expression of functional Fas antigen on adult T-cell leukemia. Leuk Res 18:305-310, 1994
53. Adkins B, Chun K, Hamilton K, Nassiri M: Naive murine neonatal T cells undergo apoptosis in response to primary stimulation. J Immunol 157:1343-1349, 1996
54. Brunner T, Mogil RJ. LaFace D, Yoo NJ, Mahboubi A, Echeverri F, Martin SJ, Force WR, Lynch DH, Ware CF, Green DR: Cell autonomous Fas(CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T cell hybridomas. Nature 373:441-444, 1995
55. Tucek-Szabo CL, Andjelic S, Lacy E, Elkon KB, Nikolic-Zugic J: Surface T cell Fas receptor/CD95 regulation, in vivo activation, and apoptosis. Activation-induced death can occur without Fas receptor. J Immunol 156:192-200, 1996